Molecular Imaging and Precision Medicine in Breast Cancer.

Molecular Imaging and Precision Medicine in Breast Cancer. PET Clin. 2017 Jan;12(1):39-51 Authors: Chudgar AV, Mankoff DA Abstract Precision medicine, basing treatment approaches on patient traits and specific molecular features of disease processes, has an important role in the management of patients with breast cancer as targeted therapies continue to improve. PET imaging offers noninvasive information that is complementary to traditional tissue biomarkers, including information about tumor burden, tumor metabolism, receptor status, and proliferation. Several PET agents that image breast cancer receptors can visually demonstrate the extent and heterogeneity of receptor-positive disease and help predict which tumors are likely to respond to targeted treatments. This review presents applications of PET imaging in the targeted treatment of breast cancer. PMID: 27863565 [PubMed - in process]
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Tags: PET Clin Source Type: research